Emergent BioSolutions Inc.’s EBS share price has surged by 5.37%, which has investors questioning if this is right time to ...

The FDA has approved a new freeze-dried formulation of Jynneos (smallpox and mpox vaccine, live, non-replicating).

Thanks to vaccines many diseases are now preventable today. Here is a closer look. At one point in history, smallpox was “one of the most devastating diseases to humanity.” With the first cases dating ...

Vaccines have saved more than 154 million lives worldwide over the past 50 years. World Immunization Week is a timely ...

In observance of World Immunisation Week, WHO's Saima Wazed emphasizes the importance of vaccines in protecting global health ...

The MVA-BN vaccine showed an overall effectiveness of 57.8% (95% CI, 11.8-83.0) in reducing mpox cases at 14 days or longer after the first dose; however, the effectiveness was lower in people ...

The freeze-dried formulation provides flexibility with regard to storage and shelf life. The Food and Drug Administration (FDA) has approved a new freeze-dried formulation of Jynneos ® (smallpox ...

Monkeypox, caused by the monkeypox virus—a close cousin of smallpox—has spread rapidly worldwide. From 2022 to 2025, more ...

Tonix Pharmaceuticals (TNXP) presented data in an oral presentation at the World Vaccine Congress Washington 2025, held April 21-24, 2025, in ...

Spillover from the politicization of the COVID pandemic has eroded vaccine confidence, but everyday people can play a role in ...

The US Food and Drug Administration (FDA) has approved the freeze-dried formulation of Bavarian Nordic’s smallpox and mpox vaccine in a move expected to provide flexibility in stockpiling the jab.

DEAR DR. ROACH: With the resurgence of measles because of declining vaccination rates, should we be wary of the same happening with smallpox (which was also thought to have been eradicated)?